The current role of model-based drug development.

The current role of model-based drug development.

Item
http://www.wikidata.org/entity/Q38028538
Recent developments in using mechanistic cardiac modelling for drug safety evaluationAgent-based modeling: a systematic assessment of use cases and requirements for enhancing pharmaceutical research and development productivityIn vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBApplications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.Translational PK-PD modeling in pain.Tools for predicting the PK/PD of therapeutic proteins.Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.Model based design and analysis of phase II HIV-1 trials.Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development.Pharmacokinetics and Half-Life of Protein TherapeuticsPharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins
P2860

The current role of model-based drug development.

Item
http://www.wikidata.org/entity/Q38028538
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The current role of model-based drug development.
@en
type
label
The current role of model-based drug development.
@en
prefLabel
The current role of model-based drug development.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The current role of model-based drug development
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698